Lacey McNally to Female
This is a "connection" page, showing publications Lacey McNally has written about Female.
Connection Strength
0.841
-
Simultaneous Detection of Multiple Tumor-targeted Gold Nanoparticles in HER2-Positive Breast Tumors Using Optoacoustic Imaging. Radiol Imaging Cancer. 2023 05; 5(3):e220180.
Score: 0.068
-
Differential expression of microRNA between triple negative breast cancer patients of African American and European American descent. Biotech Histochem. 2022 Jan; 97(1):1-10.
Score: 0.062
-
Active Targeting Significantly Outperforms Nanoparticle Size in Facilitating Tumor-Specific Uptake in Orthotopic Pancreatic Cancer. ACS Appl Mater Interfaces. 2021 Oct 27; 13(42):49614-49630.
Score: 0.061
-
Diabetes, Obesity, and Inflammation: Impact on Clinical and Radiographic Features of Breast Cancer. Int J Mol Sci. 2021 Mar 09; 22(5).
Score: 0.059
-
A New Approach for Automated Image Segmentation of Organs at Risk in Cervical Cancer. Radiol Imaging Cancer. 2020 03; 2(2):e204010.
Score: 0.055
-
Osteopontin-targeted probe detects orthotopic breast cancers using optoacoustic imaging. Biotech Histochem. 2018; 93(8):608-614.
Score: 0.050
-
Optoacoustic imaging identifies ovarian cancer using a microenvironment targeted theranostic wormhole mesoporous silica nanoparticle. Biomaterials. 2018 11; 182:114-126.
Score: 0.049
-
Detection of microspheres in vivo using multispectral optoacoustic tomography. Biotech Histochem. 2017; 92(1):1-6.
Score: 0.044
-
Identification of pancreatic tumors in vivo with ligand-targeted, pH responsive mesoporous silica nanoparticles by multispectral optoacoustic tomography. J Control Release. 2016 06 10; 231:60-7.
Score: 0.041
-
Tumor specific liposomes improve detection of pancreatic adenocarcinoma in vivo using optoacoustic tomography. J Nanobiotechnology. 2015 Dec 01; 13:90.
Score: 0.041
-
Targeting Acidity in Pancreatic Adenocarcinoma: Multispectral Optoacoustic Tomography Detects pH-Low Insertion Peptide Probes In Vivo. Clin Cancer Res. 2015 Oct 15; 21(20):4576-85.
Score: 0.040
-
Orthotopic pancreatic tumors detected by optoacoustic tomography using Syndecan-1. J Surg Res. 2015 Jan; 193(1):246-54.
Score: 0.038
-
Targeting of BRAF resistant melanoma via extracellular matrix metalloproteinase inducer receptor. J Surg Res. 2014 Jul; 190(1):111-8.
Score: 0.036
-
Chemoresistance in ovarian cancer linked to expression of microRNAs. Biotech Histochem. 2013 Oct; 88(7):403-9.
Score: 0.034
-
Lung resistance-related protein (LRP) expression in malignant ascitic cells as a prognostic marker for advanced ovarian serous carcinoma. Ann Surg Oncol. 2013 Sep; 20(9):3059-65.
Score: 0.034
-
Therapy of head and neck squamous cell carcinoma with replicative adenovirus expressing tissue inhibitor of metalloproteinase-2 and chemoradiation. Cancer Gene Ther. 2009 Mar; 16(3):246-55.
Score: 0.025
-
18F-FLT PET and Blood-based Biomarkers for Identifying Gastrointestinal Graft versus Host Disease after Allogeneic Cell Transplantation. Radiol Imaging Cancer. 2025 Jan; 7(1):e240096.
Score: 0.019
-
An integrated model of N6-methyladenosine regulators to predict tumor aggressiveness and immune evasion in pancreatic cancer. EBioMedicine. 2021 Mar; 65:103271.
Score: 0.015
-
Improved pentamethine cyanine nanosensors for optoacoustic imaging of pancreatic cancer. Sci Rep. 2021 02 23; 11(1):4366.
Score: 0.015
-
Incidence and Survival by Human Epidermal Growth Factor Receptor 2 Status in Young Women With Stage I-III Breast Cancer: SEER, 2010-2016. Clin Breast Cancer. 2020 08; 20(4):e410-e422.
Score: 0.014
-
Predictive modeling of in vivo response to gemcitabine in pancreatic cancer. PLoS Comput Biol. 2013; 9(9):e1003231.
Score: 0.009
-
Anti-tumor activity of an anti-DR5 monoclonal antibody, TRA-8, in combination with taxane/platinum-based chemotherapy in an ovarian cancer model. Gynecol Oncol. 2011 Apr; 121(1):193-9.
Score: 0.007
-
Noninvasive monitoring of mRFP1- and mCherry-labeled oncolytic adenoviruses in an orthotopic breast cancer model by spectral imaging. Mol Imaging. 2010 Apr; 9(2):59-75.
Score: 0.007
-
Anti-EMMPRIN monoclonal antibody as a novel agent for therapy of head and neck cancer. Clin Cancer Res. 2009 Jun 15; 15(12):4058-65.
Score: 0.006
-
In vivo efficacy of marimastat and chemoradiation in head and neck cancer xenografts. ORL J Otorhinolaryngol Relat Spec. 2009; 71(1):1-5.
Score: 0.006
-
Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenografts by diffusion-weighted magnetic resonance imaging. Cancer Res. 2008 Oct 15; 68(20):8369-76.
Score: 0.006
-
Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva, and eyelids): a prospective multiparametric analysis of 108 cases during 1977 to 1987. Hum Pathol. 1990 Sep; 21(9):959-73.
Score: 0.002